WO2007026382A1 - Optical fiber laser device for ocular suturing - Google Patents

Optical fiber laser device for ocular suturing Download PDF

Info

Publication number
WO2007026382A1
WO2007026382A1 PCT/IT2005/000501 IT2005000501W WO2007026382A1 WO 2007026382 A1 WO2007026382 A1 WO 2007026382A1 IT 2005000501 W IT2005000501 W IT 2005000501W WO 2007026382 A1 WO2007026382 A1 WO 2007026382A1
Authority
WO
WIPO (PCT)
Prior art keywords
flap
capsule
laser
welding
biocompatible
Prior art date
Application number
PCT/IT2005/000501
Other languages
French (fr)
Inventor
Roberto Pini
Luca Menabuoni
Ivo Lenzetti
Francesca Rossi
Jean-Marie Parel
Original Assignee
Azienda Usl 4 Prato
Consiglio Nazionale Delle Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Azienda Usl 4 Prato, Consiglio Nazionale Delle Ricerche filed Critical Azienda Usl 4 Prato
Priority to AT05794513T priority Critical patent/ATE452610T1/en
Priority to PCT/IT2005/000501 priority patent/WO2007026382A1/en
Priority to DE602005018557T priority patent/DE602005018557D1/en
Priority to US11/991,343 priority patent/US8795262B2/en
Priority to EP05794513A priority patent/EP1933788B1/en
Publication of WO2007026382A1 publication Critical patent/WO2007026382A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008Introducing ophthalmic products into the ocular cavity or retaining products therein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/00736Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • A61B2017/00504Tissue welding
    • A61B2017/00508Tissue welding using laser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30062(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F2009/00861Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00863Retina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F2009/00861Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/0087Lens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F2009/00861Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00872Cornea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F2009/00885Methods or devices for eye surgery using laser for treating a particular disease
    • A61F2009/00887Cataract
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F2009/00885Methods or devices for eye surgery using laser for treating a particular disease
    • A61F2009/00887Cataract
    • A61F2009/00889Capsulotomy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser

Definitions

  • the present invention generally relates to the field of the laser welding techniques of biological tissues and the application to ophthalmic surgery, especially for the suturing, repairing and sealing of ocular structures.
  • the invention refers to a method for preparing and laser welding flaps of biocompatible biological tissue to seal the lens capsule.
  • the present invention also relates to a fiber-optic laser radiation device for use in the performance of said operations .
  • the recommended lasers used with this method are generally of the continuous emission type, with wavelengths coming in the visible and infrared spectral bands, e.g. argon, neodymium:YAG, diode and CO 2 lasers.
  • the method involves using an exogenous chromophore (such as a biocompatible stain) with a high optical absorption at the wavelength of the laser being used.
  • Said chromophore is applied locally to the edges of the surgical wound to suture and acts as a selective absorber of the laser radiation to enable a more controlled and localized welding effect, minimizing the risk of side-effects such as heat damage to the tissues adjacent to the treatment field.
  • a "Phaco-Ersatz” or "lens refilling” method has recently been proposed for use in ophthalmic surgery, whose purpose is the aspiration of the lens and subsequent refilling of the capsule with a biocompatible polymer that simulates the optical and mechanical properties of the young lens tissue, thereby restoring the transparency and accommodation function of the healthy lens [E. Haefliger, J-M. Parel, ⁇ Accommodation of an endocapsular silicone lens (Phaco-Ersatz) in the aging rhesus monkey", Journal of Refractive Corneal Surgery 10, pp. 550-555 (1994)]. It would have a lot of applications in the treatment of some of the most common ocular disorders, such as presbyopia and lens opacification (cataract) .
  • the general object of the present invention is to provide a method for suturing, repairing and sealing ocular structures that would not involve any risk of post- operative rejection or inflammatory reactions, nor give rise to an obstruction to vision nor require the use of suturing materials, mechanical devices or adhesives that would remain as a foreign body on the surface of the ocular structure.
  • a specific object of the present invention is to provide a method of the above-mentioned type for use in repairing perforations and/or lacerations of the lens capsule tissue following an erroneous surgical maneuver or accidental trauma.
  • Another specific object of the present invention is to provide a method of the above-mentioned type suitable for use, in the so-called "Phaco-Ersatz" surgical technique, to create a valve on the capsulorhexis that enables the capsule to be filled without any leakage into the anterior chamber and the rhexis to then be permanently sealed without obstructing the patient's vision.
  • a further specific object of the present invention is to provide a method of the above-mentioned type wherein the lens capsule is sealed by applying flaps of biocompatible biological and optically transparent tissue and welding said flaps to the capsule by means of laser radiation.
  • a further object of the present invention is to provide a method for preparing flaps of biocompatible biological tissue suitable for use in suturing, repairing and sealing ocular structures by means of a laser-induced welding method, and particularly in the creation of a valve and/or closure on the lens capsule both in its normal physiological state and after it has been emptied of its contents.
  • Another object of the present invention is to provide a device for the laser-induced welding of flaps of biological tissue in a fluid environment .
  • Another object of the present invention is to provide a device of the above-mentioned type comprising a laser generator and a fiber-optic system for conveying the laser beam by means of an applicator handpiece suitable for welding the flaps of biocompatible biological tissue onto the lens capsule so that they serve both as a valve and as a final seal over a capsulorhexis .
  • figure 1 shows a typical absorption spectrum for porcine capsular tissue stained with Indocyanine Green in a sterile water solution, as measured in fresh tissue
  • FIG. 1 shows a block diagram of the equipment for checking the absorption spectrum of the stained flap
  • figure 3 shows a possible embodiment of the laser device, optical fiber and handpiece used to apply the laser radiation, with a detail of how said handpiece is inserted in the anterior chamber of the eye
  • figures 4, 5, 6, 7, 8 and 9 schematically show the surgical procedure involved in aspirating the lens and refilling the capsule with a biocompatible polymer (the Phaco-Ersatz method) through a valve made according to the invention.
  • the method for suturing, repairing and sealing ocular structures involves the use of flaps, as will be described in more detail later on, of biocompatible biological tissue that are applied and welded over a discontinuity or perforation in said ocular structures using a laser-induced welding method.
  • flaps as will be described in more detail later on, of biocompatible biological tissue that are applied and welded over a discontinuity or perforation in said ocular structures using a laser-induced welding method.
  • the flaps of tissue used for said purpose can be prepared from capsule tissue, particularly flaps of anterior capsule explanted post-mortem from a human donor (10 micron thick) or porcine tissue (30 micron thick) .
  • Said tissue consists essentially of collagen and elastin, with a limited cellular component, which is usually removed by washing at the time of its explantation.
  • other natural biological tissues such as amniotic membrane, or artificial tissues composed of collagen and/or elastin and suitably structured so as to reproduce the morphology, transparency and mechanical resistance of the above-mentioned natural tissues, may also be used (see for instance: B. P.
  • the flap of anterior capsule is spread on a microscope slide, with the original inner surface uppermost, since this is the one to stain with the chromophore . It is essential to control the flap's orientation throughout the preparatory stages in order to ensure that the donor flap is repositioned on the recipient capsule so that the curvatures of the two surfaces coincide, since this facilitates a better adhesion. Then the chromophore can be applied.
  • the choice of chromophore to use depends strictly on the type of laser that will be used because the absorption band of the chromophore has to include the emission wavelength of the laser to achieve the chromophore- mediated laser welding.
  • the chromophore consists of a sterile water solution of Indocyanine Green (indicated below by the abbreviation ICG) , a substance widely used in ophthalic surgery, both as a contrast medium and as a photosensitizer, so its toxicological features are well known.
  • ICG Indocyanine Green
  • ICG has strong absorption features at near infrared wavelengths, around 800 nanometers.
  • the shape of the absorption spectrum curve for ICG depends on the type of solvent used, the concentration of ICG in the solution (see for instance: M. L. J. Landsman, G. Kwant, G. A. Mook, W. G. Zijlstra, "Light-absorbing properties, stability, and spectral stabilization of indocyanine green", J. Appl . Physiol. 40, pp. 575-583 (1976)], and finally on the type of tissue to which the ICG binds.
  • the staining procedure is as follows: the flap is placed on the glass slide and kept adequately hydrated; using a calibrated microsyringe a drop of stain solution is applied to the exposed surface, taking care to avoid it spreading beyond the edges and thus staining the underside of the flap in contact with the glass. The drop is left in place for a few minutes (said time is optimized according to the type of tissue being used, typically 10 minutes for the example described herein) to allow for the stain to be absorbed by the exposed surface of the tissue. Then the flap is abundantly washed with sterile water to remove any residual traces of unabsorbed stain. The result is a flap stained only on the exposed side, which is the side that will be placed in contact with the surface of the recipient capsule when the laser-induced welding is performed.
  • the continuous line in figure 1 shows the typical absorption spectrum for a flap of porcine anterior capsule stained with one drop of a sterile water solution of ICG 4.4% left in place for 10 minutes before it was washed and measured with the spectrophotometer.
  • the spectrum clearly shows a wide absorption band between 700 and 800 nanometers, in which there can be comprised the emissions of various types of laser for the welding procedure, such as the aluminium gallium arsenide
  • AlGaAs diode laser which has an emission at approximately 800 nanometers, good efficiency characteristics and a more than adequate power rating for the needs of the present invention.
  • this type of laser as the chosen source of radiation.
  • the flaps to use in surgical practice in humans can be checked using an instrumentation of the type illustrated in figure 2, which has the advantage of being portable and not contaminating the flaps already sterilized for clinical use.
  • the instrument comprises an illuminator 1, consisting of a tungsten-krypton lamp, for instance, with an optical fiber 2 for illuminating the capsule flap tissue contained in a sterile cell 3 made of transparent plastic material.
  • the light that passes through the tissue is collected by a second optical fiber 4, connected to a portable spectrometer 5 (for instance, the illuminator lamp and spectrometer can be the Tungsten- Krypton SLl light source and the Portable Spectrometer Mod. EPP-2000-VIS-100 manufactured by STELLAR NET Inc., USA) .
  • the spectrometer acquires the absorption spectrum of the stained flap, which is then saved on a computer 6.
  • the flap can be used immediately for surgery, or it can be preserved, e.g. snap frozen in liquid nitrogen or dehydrated.
  • the dotted line shows the absorption spectrum of a flap of capsule that was dehydrated after staining and then rehydrated seven days later. It is possible to notice that the curve does not differ substantially from that of the fresh tissue, represented by the continuous line.
  • the equipment forming the laser system for welding biological tissues comprises a laser 15 with a fiber-optic transmission 14 and an applicator handpiece 7.
  • said laser may be, as mentioned earlier, an AlGaAs diode laser emitting at 810 nm and a power of 0.5-10W, capable of both continuous and pulsing operation, such as the Smarty A- 800 laser manufactured by El. En. spa of Calenzano (FI) , Italy.
  • Said laser beam is transmitted via an optical fiber 14 with a 200 micron core connected to an applicator handpiece, according to the present invention.
  • FIG. 3 also shows a preferred embodiment of the applicator handpiece used to perform the laser welding of the flap in more detail .
  • the handpiece includes a cylindrical grip 7 with the size of a pen, made of plastic or metal, with a spindle 8 at the rear end for locking the jacket of the optical fiber 14 in place, and a needle 9 at the front end, the terminal part of which is bent axially, with the end of the optical fiber extending therefrom.
  • Said handpiece like the optical fiber, is made of sterilizable materials suitable for clinical uses.
  • the needle 9 is of a suitable length (e.g. 2-3 cm) for inserting in the anterior chamber of the eye, which is delimited between the cornea 10 and the lens 11, through a corneal or sclero-corneal tunnel, indicated by the numeral 12, in order to reach the surface of the lens capsule on which the flap of tissue 13 to be welded has been applied.
  • the bent shape of the needle 9 serves the purpose of enabling a moderate pressure to be exerted on the flap to be welded, thus ensuring a good contact between the flap and the surface of the capsule, expelling any fluid of the anterior chamber from the interface.
  • staining only the side of the flap coming into contact with the surface of the recipient capsule serves to ensure that the laser radiation is only absorbed at the interface between said surfaces, so that the welding effect is highly localized and selective, with the advantage of enabling a reduction in the dose of laser radiation needed to complete the weld and thus also minimizing the risk of heat damage to the tissues adjacent to the treated area.
  • the end of the optical fiber does not become soiled by said contact because the stained surface is the one on the other side of the flap, facing the surface of the capsule.
  • the welding spot can be perfectly controlled both in terms of shape and size (the spot welds correspond exactly to the delivery area of the fiber, which is 200 micron in diameter) and in terms of the laser energy per unit of surface area (or fluency) applied to the tissue. In fact, this avoids any variability in the distance of the fiber from the irradiated surface, which affects the fluency because the emission of the fiber is inherently diverging. This makes the application of the laser welding highly reproducible .
  • FIG. 4 shows the principal steps in said procedure, and schematically illustrate the anterior chamber of the eye as seen through the cornea.
  • figure 4 shows the preparation of an access route into the anterior chamber using a method similar to the one adopted in cataract phaco-emulsification surgery, i.e.
  • a sclero-corneal tunnel 16 created surgically with a precalibrated scalpel (2.75-3.5 mm wide) ; one or two narrower (1 mm) additional service channels, indicated by the numerals 17 and 18 in figure 4, are usually also created to facilitate intraocular maneuvers.
  • the next step, as illustrated in figure 5, is the capsulorhexis approximately 1 mm in diameter on the anterior capsule. Said rhexis is used to aspirate the contents of the lens, e.g. using a phaco-emulsifier as illustrated in figure 6, then the capsule can be refilled with hyaluronic acid, injected through the capsulorhexis .
  • the tissue flap prepared as explained earlier is then inserted through the sclero-corneal tunnel 16 and positioned on the anterior capsule, as schematically shown in figure 7, with the aid of microtweezers, so as to cover the rhexis entirely.
  • the flap is welded around the circumference of the rhexis using the applicator handpiece and the radiation technique previously described, according to the present invention.
  • the welding is completed by means of adjacent spot welds. Instead of completing the weld around the full circumference of the flap, one quadrant of the flap is initially left free.
  • the partially welded flap thus serves as a valve through which the capsule can subsequently be filled with a biocompatible polymer, as shown in figure 9. Finally, the valve is closed using the method already illustrated in figure 8, completing the welding around the full circumference so as to seal in the contents.
  • the polymer used to fill the capsule can be submitted to irradiation from the outside to induce its polymerization without any need to remove the capsule at the end of said operation.
  • a pulsing radiation method can be used for the laser-induced welding of capsule tissue, instead of the continuous irradiation more frequently used for other types of tissue.
  • Said pulsing mode is particularly suitable for the contact-type welding procedure forming the object of the present invention and has the advantage of reducing the interaction time with the ocular structures, which are particularly vulnerable, thereby limiting the propagation of heat to the adjacent tissues and the related risk of heat damage.
  • Typical parameters for use with this irradiation method are, for instance: a pulse duration between 50 and 150 ms, with a single-pulse energy coming between 20 and 100 milliJoules.
  • the method according to the present invention can also be advantageously applied to fix corneal or intraocular prostheses, e.g. contact lenses, IOL, and so on, as well as to contain retinal detachments or seal retinal perforations.

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Prostheses (AREA)
  • Laser Surgery Devices (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
  • Laser Beam Processing (AREA)

Abstract

A method for suturing the lens capsule of the eye in the event of accidental rupture thereof or to create a valve and/or to close a capsulorhexis by means of laser-induced welding onto the capsule’s surface of a flap of biocompatible biological tissue prepared so as to be optically absorbent at the wavelength of the laser being used for the welding. The method is suitable for use in the so-called Phaco-Ersatz or “lens refilling” ophthalmic surgery. The welding is done using laser devices that comprises of a laser generator and a fiberoptic system for conveying the laser beam, complete with an applicator handpiece suitable for use in welding said flaps onto the lens capsule in a liquid environment. The handpiece is shaped so as to exert a moderate pressure on the tissues to be welded with the free end of the optical fiber.

Description

TITLE
OPTICAL FIBER LASERDEVICE FOROCULAR STRUCTURES
DESCRIPTION
Field of the invention
The present invention generally relates to the field of the laser welding techniques of biological tissues and the application to ophthalmic surgery, especially for the suturing, repairing and sealing of ocular structures.
In particular, the invention refers to a method for preparing and laser welding flaps of biocompatible biological tissue to seal the lens capsule.
The present invention also relates to a fiber-optic laser radiation device for use in the performance of said operations .
Background art
As is known, the laser-induced welding techniques of biological tissues have been proposed and studied at experimental level to assess their possible application in surgery with a view to suturing various types of tissue, e.g. skin, blood vessel walls, nerve tissue and others
[K.M. McNally-Heintzelman, "Laser Tissue Welding", Chap.
39 in: Biomedical Photonics Handbook, pp. 39-1/39-45, T. Vo-Dinh, Ed., CRC Press, Boca Raton (2003)]. These techniques are based on the application of laser radiation to the biological tissues, which has the effect of activating certain proteins in the extracellular matrix, such as collagen and elastin, and inducing the immediate adhesion of the wound edges .
The recommended lasers used with this method are generally of the continuous emission type, with wavelengths coming in the visible and infrared spectral bands, e.g. argon, neodymium:YAG, diode and CO2 lasers.
In some cases, the method involves using an exogenous chromophore (such as a biocompatible stain) with a high optical absorption at the wavelength of the laser being used. Said chromophore is applied locally to the edges of the surgical wound to suture and acts as a selective absorber of the laser radiation to enable a more controlled and localized welding effect, minimizing the risk of side-effects such as heat damage to the tissues adjacent to the treatment field.
In ophthalmic surgery, the laser-induced welding of biological tissues can be exploited for various purposes, as an alternative for instance to conventional suturing methods for closing corneal lesions in cataract and corneal transplant surgery [F. Rossi, R. Pini, L. Menabuoni, R. Mencucci, U. Menchini, S. Ambrosini, G. Vannelli, "Experimental study on the healing process following laser welding of the cornea" , Journal of Biomedical Optics 10, pp. 1-7 (2005)].
Various radiation methods are currently used in the laser welding of biological tissues, with and without the aid of a chromophore :
1) direct irradiation, e.g. by means of an articulated arm, especially for laser wavelengths that cannot be transmitted by optical fibers (e.g. those produced by the CO2 laser) ;
2) operating microscope-guided irradiation, in which case the wound to be welded can be scanned with a beam- splitter used to couple the laser beam to the optical microscope [J. Tang, G.Godlewski, S.Rouy, G.Delacretaz, "Morphologic changes in collagen fibers after 830 nm diode laser welding", Lasers in Surgery and Medicine 21, pp. 438-443 (1997) ] ;
3) irradiation via optical fibers, keeping the end of the optical fiber emitting the beam a suitable distance from the surface of the tissue (typically a few millimeters away) to avoid soiling the fiber, especially if a stain is used, since this would lead to a substantial reduction in the power transmitted.
One of the problems that remain to be solved in ophthalmgic surgery is how to repair the capsule containing the lens, because the wall of the capsule is extremely slender (10 micrometers) and under considerable tension, so conventional sutures cannot be used. For instance in cataract surgery involving the implantation of an intraocular lens (IOL) , the rear wall of the capsule must be preserved in order to prevent the vitreous humor from penetrating into the anterior chamber. One of the most common complications of this type of surgery is represented by the perforation or laceration of the capsule wall as a result of an erroneous manipulation by the surgeon .
The problem of capsule repair is also still without solution in cases of perforating trauma involving the lens, which often gives rise to a severe inflammatory reaction (anaphylactic uveitis) , followed by the onset of a post-traumatic cataract. These complications might be avoided if an efficient capsule suturing method were available ;
A "Phaco-Ersatz" or "lens refilling" method has recently been proposed for use in ophthalmic surgery, whose purpose is the aspiration of the lens and subsequent refilling of the capsule with a biocompatible polymer that simulates the optical and mechanical properties of the young lens tissue, thereby restoring the transparency and accommodation function of the healthy lens [E. Haefliger, J-M. Parel, ΛΛAccommodation of an endocapsular silicone lens (Phaco-Ersatz) in the aging rhesus monkey", Journal of Refractive Corneal Surgery 10, pp. 550-555 (1994)]. It would have a lot of applications in the treatment of some of the most common ocular disorders, such as presbyopia and lens opacification (cataract) . One of the problems still to be solved before the method can be used in clinical practice, however, is how to close the opening in the capsule (or rhexis) used to aspirate the old lens and subsequently refill the capsule.
Mechanical sealing devices have been proposed to solve this problem, such as plastic valves, but these have to be removed at a later date [0. Nishi, K. Nishi, "Accommodation amplitude after lens refilling with injectable silicone by sealing the capsule with a plug in primates", Archives of Ophthalmology 116, pp. 1358-61 (1998)] . Such mechanical valves have been tested at experimental level in an animal model to fill the capsule without the polymer leaking into the anterior chamber, but they would hardly be suitable for use in humans because, if they were left in place, they would become a foreign body that would partially obstruct the vision, interfering with lens accommodation and giving rise to various inflammatory or rejection processes during the healing period. Moreover, removing them - after the polymer has been irradiated from the outside to ensure its polymerization - would involve accessing the anterior chamber again and, in any case, the rhexis in the capsule would be left open. Summary of the invention
The general object of the present invention is to provide a method for suturing, repairing and sealing ocular structures that would not involve any risk of post- operative rejection or inflammatory reactions, nor give rise to an obstruction to vision nor require the use of suturing materials, mechanical devices or adhesives that would remain as a foreign body on the surface of the ocular structure. A specific object of the present invention is to provide a method of the above-mentioned type for use in repairing perforations and/or lacerations of the lens capsule tissue following an erroneous surgical maneuver or accidental trauma. Another specific object of the present invention is to provide a method of the above-mentioned type suitable for use, in the so-called "Phaco-Ersatz" surgical technique, to create a valve on the capsulorhexis that enables the capsule to be filled without any leakage into the anterior chamber and the rhexis to then be permanently sealed without obstructing the patient's vision.
A further specific object of the present invention is to provide a method of the above-mentioned type wherein the lens capsule is sealed by applying flaps of biocompatible biological and optically transparent tissue and welding said flaps to the capsule by means of laser radiation.
It is still another specific object of the present invention to provide a method of the above-stated type wherein the flaps of biocompatible biological tissue are made capable of selectively absorbing the laser radiation by means of a treatment with a chromophore that serves the purpose of localizing the effect of the laser-induced welding and thus reducing the heat damage to tissues adjacent to the area to be treated.
A further object of the present invention is to provide a method for preparing flaps of biocompatible biological tissue suitable for use in suturing, repairing and sealing ocular structures by means of a laser-induced welding method, and particularly in the creation of a valve and/or closure on the lens capsule both in its normal physiological state and after it has been emptied of its contents.
Another object of the present invention is to provide a device for the laser-induced welding of flaps of biological tissue in a fluid environment . Another object of the present invention is to provide a device of the above-mentioned type comprising a laser generator and a fiber-optic system for conveying the laser beam by means of an applicator handpiece suitable for welding the flaps of biocompatible biological tissue onto the lens capsule so that they serve both as a valve and as a final seal over a capsulorhexis .
These objects are achieved by the method for suturing, repairing and sealing ocular structures and the method for preparing biocompatible biological tissue flaps, and the device for laser welding in a fluid environment according to the present invention, the fundamental characteristics of which are set forth in claims 1, 8, 12 and .14, while further important characteristics of the invention are stated in the dependent claims.
Brief description of the drawings
The characteristics and advantages of the method for suturing, repairing and sealing ocular structures, of the method for preparing biocompatible biological tissue flaps, and of the laser device for use in said suturing, repairing and sealing method according to the invention, will be apparent from the following description of a preferred embodiment of the invention, which is given as a non-limiting example with reference to the attached drawings, wherein: figure 1 shows a typical absorption spectrum for porcine capsular tissue stained with Indocyanine Green in a sterile water solution, as measured in fresh tissue
(continuous line) and in tissue that has been dehydrated and then rehydrated 7 days later (dotted line) ; figure 2 shows a block diagram of the equipment for checking the absorption spectrum of the stained flap; figure 3 shows a possible embodiment of the laser device, optical fiber and handpiece used to apply the laser radiation, with a detail of how said handpiece is inserted in the anterior chamber of the eye; figures 4, 5, 6, 7, 8 and 9 schematically show the surgical procedure involved in aspirating the lens and refilling the capsule with a biocompatible polymer (the Phaco-Ersatz method) through a valve made according to the invention. Detailed description of the invention
The method for suturing, repairing and sealing ocular structures according to the present invention involves the use of flaps, as will be described in more detail later on, of biocompatible biological tissue that are applied and welded over a discontinuity or perforation in said ocular structures using a laser-induced welding method. Having to operate in a liquid environment, such as the anterior chamber of the eye, the staining solution needed to ensure a selective absorption of the laser radiation cannot be applied topically to the two sides of tissue to be welded. Moreover, no liquid must come between the tissues to be welded during the welding process.
According to a preferred embodiment of the present invention, the flaps of tissue used for said purpose can be prepared from capsule tissue, particularly flaps of anterior capsule explanted post-mortem from a human donor (10 micron thick) or porcine tissue (30 micron thick) . Said tissue consists essentially of collagen and elastin, with a limited cellular component, which is usually removed by washing at the time of its explantation. Alternatively, other natural biological tissues, such as amniotic membrane, or artificial tissues composed of collagen and/or elastin and suitably structured so as to reproduce the morphology, transparency and mechanical resistance of the above-mentioned natural tissues, may also be used (see for instance: B. P. Chan, "A Photochemical Crosslinking Technology for Tissue Engineering - Enhancement of the Physico-Chemical Properties of Collagen-based Scaffolds" , Proceedings of SPIE Volume 5695, pp. 317-327 (2005)). For the sake of simplicity, in the following description reference will only be made to natural flaps of anterior capsule in the shape of a circular disc approximately 2 mm in diameter and a few tens micron thick. The method for preparing the flap is described in detail.
When the capsule is explanted from the donor, the flap of anterior capsule is spread on a microscope slide, with the original inner surface uppermost, since this is the one to stain with the chromophore . It is essential to control the flap's orientation throughout the preparatory stages in order to ensure that the donor flap is repositioned on the recipient capsule so that the curvatures of the two surfaces coincide, since this facilitates a better adhesion. Then the chromophore can be applied.
The choice of chromophore to use depends strictly on the type of laser that will be used because the absorption band of the chromophore has to include the emission wavelength of the laser to achieve the chromophore- mediated laser welding. In one possible embodiment, the chromophore consists of a sterile water solution of Indocyanine Green (indicated below by the abbreviation ICG) , a substance widely used in ophthalic surgery, both as a contrast medium and as a photosensitizer, so its toxicological features are well known.
From the point of view of its optical properties, ICG has strong absorption features at near infrared wavelengths, around 800 nanometers. As known to a person skilled in the art, the shape of the absorption spectrum curve for ICG depends on the type of solvent used, the concentration of ICG in the solution (see for instance: M. L. J. Landsman, G. Kwant, G. A. Mook, W. G. Zijlstra, "Light-absorbing properties, stability, and spectral stabilization of indocyanine green", J. Appl . Physiol. 40, pp. 575-583 (1976)], and finally on the type of tissue to which the ICG binds. To obtain an efficient laser welding of the tissue stained with ICG, it is consequently fundamental to identify the optimal concentration of ICG in the solution to use beforehand, and subsequently have an apparatus available (preferably a portable unit suitable for use in the operating room) to check whether the flap stained with the solution has the right absorption coefficient for the wavelength of the laser generator.
In a possible embodiment of the present invention, the staining procedure is as follows: the flap is placed on the glass slide and kept adequately hydrated; using a calibrated microsyringe a drop of stain solution is applied to the exposed surface, taking care to avoid it spreading beyond the edges and thus staining the underside of the flap in contact with the glass. The drop is left in place for a few minutes (said time is optimized according to the type of tissue being used, typically 10 minutes for the example described herein) to allow for the stain to be absorbed by the exposed surface of the tissue. Then the flap is abundantly washed with sterile water to remove any residual traces of unabsorbed stain. The result is a flap stained only on the exposed side, which is the side that will be placed in contact with the surface of the recipient capsule when the laser-induced welding is performed.
Then measurements are taken to characterize the absorption spectrum of the stained flap. A laboratory spectrophotometer can be used to take the preliminary measurements for the preclinical optimization procedure, placing the stained flap in a normal analysis cell . As an example, the continuous line in figure 1 shows the typical absorption spectrum for a flap of porcine anterior capsule stained with one drop of a sterile water solution of ICG 4.4% left in place for 10 minutes before it was washed and measured with the spectrophotometer.
The spectrum clearly shows a wide absorption band between 700 and 800 nanometers, in which there can be comprised the emissions of various types of laser for the welding procedure, such as the aluminium gallium arsenide
(AlGaAs) diode laser, which has an emission at approximately 800 nanometers, good efficiency characteristics and a more than adequate power rating for the needs of the present invention. In the description that follows, reference is made to this type of laser as the chosen source of radiation.
After identifying the ICG's optimal concentration and application times on the flap, the flaps to use in surgical practice in humans can be checked using an instrumentation of the type illustrated in figure 2, which has the advantage of being portable and not contaminating the flaps already sterilized for clinical use. With reference to the figure, the instrument comprises an illuminator 1, consisting of a tungsten-krypton lamp, for instance, with an optical fiber 2 for illuminating the capsule flap tissue contained in a sterile cell 3 made of transparent plastic material. The light that passes through the tissue is collected by a second optical fiber 4, connected to a portable spectrometer 5 (for instance, the illuminator lamp and spectrometer can be the Tungsten- Krypton SLl light source and the Portable Spectrometer Mod. EPP-2000-VIS-100 manufactured by STELLAR NET Inc., USA) . The spectrometer acquires the absorption spectrum of the stained flap, which is then saved on a computer 6.
After testing in this way, the flap can be used immediately for surgery, or it can be preserved, e.g. snap frozen in liquid nitrogen or dehydrated. With reference to figure 1, the dotted line shows the absorption spectrum of a flap of capsule that was dehydrated after staining and then rehydrated seven days later. It is possible to notice that the curve does not differ substantially from that of the fresh tissue, represented by the continuous line.
The equipment forming the laser system for welding biological tissues, schematically illustrated in figure 3, comprises a laser 15 with a fiber-optic transmission 14 and an applicator handpiece 7. In a possible embodiment, said laser may be, as mentioned earlier, an AlGaAs diode laser emitting at 810 nm and a power of 0.5-10W, capable of both continuous and pulsing operation, such as the Smarty A- 800 laser manufactured by El. En. spa of Calenzano (FI) , Italy. Said laser beam is transmitted via an optical fiber 14 with a 200 micron core connected to an applicator handpiece, according to the present invention.
Figure 3 also shows a preferred embodiment of the applicator handpiece used to perform the laser welding of the flap in more detail . The handpiece includes a cylindrical grip 7 with the size of a pen, made of plastic or metal, with a spindle 8 at the rear end for locking the jacket of the optical fiber 14 in place, and a needle 9 at the front end, the terminal part of which is bent axially, with the end of the optical fiber extending therefrom. Said handpiece, like the optical fiber, is made of sterilizable materials suitable for clinical uses.
Referring again to figure 3, which shows a possible use of the handpiece forming the object of the present invention to close a capsulorhexis, the needle 9 is of a suitable length (e.g. 2-3 cm) for inserting in the anterior chamber of the eye, which is delimited between the cornea 10 and the lens 11, through a corneal or sclero-corneal tunnel, indicated by the numeral 12, in order to reach the surface of the lens capsule on which the flap of tissue 13 to be welded has been applied. The bent shape of the needle 9 serves the purpose of enabling a moderate pressure to be exerted on the flap to be welded, thus ensuring a good contact between the flap and the surface of the capsule, expelling any fluid of the anterior chamber from the interface. In fact, this is an essential condition for an efficient laser welding between the surfaces of two biological tissues because, at microscopic level, a direct link has to be created between the collagen fibers on the two surfaces being welded together, thanks to the photo-thermal effect induced by the laser radiation.
On this aspect, staining only the side of the flap coming into contact with the surface of the recipient capsule serves to ensure that the laser radiation is only absorbed at the interface between said surfaces, so that the welding effect is highly localized and selective, with the advantage of enabling a reduction in the dose of laser radiation needed to complete the weld and thus also minimizing the risk of heat damage to the tissues adjacent to the treated area.
The absorption of the chromophore only on the surface interfacing with that of the capsular tissue, as described in the preparation of the materials, and the absence of any gap between the interfaces to be welded, ensured by the fact that the laser radiation is performed with the optical fiber in contact and exerting a moderate pressure that removes any liquid coming between the two surfaces, make it possible to obtain a laser welding of tissues even in a liquid environment such as that of the anterior chamber of the eye.
Moreover, the end of the optical fiber does not become soiled by said contact because the stained surface is the one on the other side of the flap, facing the surface of the capsule.
Thanks to said radiation by contact, the welding spot can be perfectly controlled both in terms of shape and size (the spot welds correspond exactly to the delivery area of the fiber, which is 200 micron in diameter) and in terms of the laser energy per unit of surface area (or fluency) applied to the tissue. In fact, this avoids any variability in the distance of the fiber from the irradiated surface, which affects the fluency because the emission of the fiber is inherently diverging. This makes the application of the laser welding highly reproducible .
The method for preparing the flaps and the equipment for the laser-induced welding of said flaps to ocular tissues according to the present invention consequently enables the creation of a valve and the sealing of a capsulorhexis, as needed, for instance, in the surgical procedure based on the Phaco-Ersatz technique. Figures 4, 5, 6, 7 and 8 show the principal steps in said procedure, and schematically illustrate the anterior chamber of the eye as seen through the cornea. In particular, figure 4 shows the preparation of an access route into the anterior chamber using a method similar to the one adopted in cataract phaco-emulsification surgery, i.e. by means of a sclero-corneal tunnel 16 created surgically with a precalibrated scalpel (2.75-3.5 mm wide) ; one or two narrower (1 mm) additional service channels, indicated by the numerals 17 and 18 in figure 4, are usually also created to facilitate intraocular maneuvers. The next step, as illustrated in figure 5, is the capsulorhexis approximately 1 mm in diameter on the anterior capsule. Said rhexis is used to aspirate the contents of the lens, e.g. using a phaco-emulsifier as illustrated in figure 6, then the capsule can be refilled with hyaluronic acid, injected through the capsulorhexis . The tissue flap prepared as explained earlier is then inserted through the sclero-corneal tunnel 16 and positioned on the anterior capsule, as schematically shown in figure 7, with the aid of microtweezers, so as to cover the rhexis entirely. Great care is taken during this step to ensure that the stained side faces the surface of the capsule. As shown in figure 8, the flap is welded around the circumference of the rhexis using the applicator handpiece and the radiation technique previously described, according to the present invention. In the example in figure 8, the welding is completed by means of adjacent spot welds. Instead of completing the weld around the full circumference of the flap, one quadrant of the flap is initially left free. The partially welded flap thus serves as a valve through which the capsule can subsequently be filled with a biocompatible polymer, as shown in figure 9. Finally, the valve is closed using the method already illustrated in figure 8, completing the welding around the full circumference so as to seal in the contents. Where necessary, the polymer used to fill the capsule can be submitted to irradiation from the outside to induce its polymerization without any need to remove the capsule at the end of said operation.
It should be noted that the welding can only be done efficiently for certain laser emission parameters, which depend on the type of tissue being irradiated and the concentration of stain. Referring to the preferred embodiment described herein, as a non-limiting example, a pulsing radiation method can be used for the laser-induced welding of capsule tissue, instead of the continuous irradiation more frequently used for other types of tissue. Said pulsing mode is particularly suitable for the contact-type welding procedure forming the object of the present invention and has the advantage of reducing the interaction time with the ocular structures, which are particularly vulnerable, thereby limiting the propagation of heat to the adjacent tissues and the related risk of heat damage. Typical parameters for use with this irradiation method are, for instance: a pulse duration between 50 and 150 ms, with a single-pulse energy coming between 20 and 100 milliJoules. Finally, it should be noted that the method according to the present invention can also be advantageously applied to fix corneal or intraocular prostheses, e.g. contact lenses, IOL, and so on, as well as to contain retinal detachments or seal retinal perforations.
Variations and modifications of the present invention may be appreciated based on a review of the description. Any such changes and additions are intended to be within the spirit and scope of the present invention, as defined by in the following claims .

Claims

1. Method for suturing, repairing and sealing ocular structures, characterized in that it involves using a flap of optically transparent, biocompatible biological tissue for application over a surface discontinuity or perforation in said ocular structure, said flap subsequently being fixed to the surface of said ocular structure by means of a laser-induced welding.
2. Method as set forth in claim 1, wherein said ocular structure is the lens capsule and said surface discontinuity or perforation is incurred as a result of an erroneous surgical maneuver or following accidental trauma.
3. Method as set forth in claim 2, comprising the following steps: a) positioning over said discontinuity or perforation of a flap of biocompatible biological tissue, treated with a biocompatible chromophore chosen in such a way that its optical absorbance band includes the emission wavelength of the laser being used, so that the side of the flap treated with said chromophore is facing and in contact with the surface of the capsule, b) welding said flap onto the surface of the capsule by irradiation with a laser beam transmitted by an optical fiber in order to seal said discontinuity or perforation.
4. Method as set forth in claim 1, wherein said ocular structure is the lens capsule and said surface discontinuity or perforation is a capsulorhexis performed as part of the Phaco-Ersatz surgical technique, said flap being partially welded to the surface of the capsule surrounding said rhexis and thus serving as a valve for delivering a biocompatible material inside said capsule and subsequently, after completing the welding, as a cover over said rhexis, for sealing in the contents of the capsule.
5. Method as set forth in claim 4, comprising the following steps : a) preparing an access route into the anterior chamber of the eye by surgically creating a sclero-corneal tunnel to enable capsulorhexis and the removal of the content of the capsule, b) inserting through said tunnel in the anterior chamber a flap of biocompatible biological tissue treated with a biocompatible chromophore chosen in such a way that its optical absorbance band includes the emission wavelength of the laser being used, c) applying said flap over the anterior capsule at said rhexis so that the side of the flap treated with said chromophore is facing and in contact with the surface of the capsule, d) partially welding said flap onto the surface of the capsule by irradiation with a laser beam transmitted through an optical fiber, in such a way to leave a passage for the delivery of a biocompatible material, e) completing the welding around said flap on the surface of the capsule to seal the rhexis formed thereon.
6. Method as set forth in any of the previous claims, wherein said flap is fixed by means of laser-induced welding obtained by irradiation of a laser beam emitted from the end of an optical fiber connected to a laser generator, said end being brought into contact with said flap and exerting a moderate pressure thereon.
7. Method as set forth in any of the previous claims, wherein said flap undergoes a test on its absorbance before it is attached to the capsule.
8. Method for preparing biocompatible biological tissue flaps for use in the suturing, repairing and sealing of ocular structures by means of a laser-induced welding characterized in that it comprises the following steps: a) providing a flap of biocompatible biological tissue, b) preparing a solution of biocompatible chromophore chosen such that its optical absorption band includes the emission wavelength of the laser being used, c) staining the side of said flap which is destined to face the surface of said ocular structure, with said chromophore, d) testing the absorbance level of the resulting stained flap, e) optionally, freezing and/or dehydrating said stained flap to preserve it unless it is intended for immediate use.
9. Method as set forth in claim 8, wherein said chromophore is an aqueous solution of Indocyanine Green.
10. Method as set forth in any of the previous claims, wherein said flap of biocompatible biological tissue is of natural or artificial type.
11. Method as set forth in claim 10, wherein said flap of biocompatible biological tissue of natural type is lens capsule tissue obtained from a human donor post-mortem or from pig or from amniotic membrane, or other similar biological tissues.
12. Device for welding biological tissues consisting of a laser generator and an optical fiber for conveying the laser radiation to an applicator handpiece, characterized in that said applicator handpiece comprises of a needle with an axially bent terminal portion, said needle containing said optical fiber, one end of which emerges from the free end of said bent terminal portion of needle.
13. Device as set forth in claim 12, wherein said needle extends from a grip for supporting said optical fiber.
14. Applicator handpiece for a laser beam carried by an optical fiber connected to a laser generator, characterized in that a needle extends therefrom with an axially bent terminal portion, said optical fiber extending through said needle with its end emerging from the free end of said bent terminal portion.
PCT/IT2005/000501 2005-08-30 2005-08-30 Optical fiber laser device for ocular suturing WO2007026382A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AT05794513T ATE452610T1 (en) 2005-08-30 2005-08-30 PREPARATION OF EYE FLAPS FOR LASER WELDING PROCESS
PCT/IT2005/000501 WO2007026382A1 (en) 2005-08-30 2005-08-30 Optical fiber laser device for ocular suturing
DE602005018557T DE602005018557D1 (en) 2005-08-30 2005-08-30 PREPARING EYESHADOWS FOR LASER WELDING PROCESS
US11/991,343 US8795262B2 (en) 2005-08-30 2005-08-30 Optical fiber laser device and method for ocular suturing
EP05794513A EP1933788B1 (en) 2005-08-30 2005-08-30 Preparing ocular flaps for laser welding

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2005/000501 WO2007026382A1 (en) 2005-08-30 2005-08-30 Optical fiber laser device for ocular suturing

Publications (1)

Publication Number Publication Date
WO2007026382A1 true WO2007026382A1 (en) 2007-03-08

Family

ID=36217956

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2005/000501 WO2007026382A1 (en) 2005-08-30 2005-08-30 Optical fiber laser device for ocular suturing

Country Status (5)

Country Link
US (1) US8795262B2 (en)
EP (1) EP1933788B1 (en)
AT (1) ATE452610T1 (en)
DE (1) DE602005018557D1 (en)
WO (1) WO2007026382A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9555111B2 (en) 2012-03-29 2017-01-31 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
US10575986B2 (en) 2012-03-29 2020-03-03 Cxl Ophthalmics, Llc Ophthalmic treatment solution delivery devices and delivery augmentation methods

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6997923B2 (en) * 2000-12-28 2006-02-14 Palomar Medical Technologies, Inc. Method and apparatus for EMR treatment
US20080306471A1 (en) * 2000-12-28 2008-12-11 Palomar Medical Technologies, Inc. Methods and devices for fractional ablation of tissue
JP2005535370A (en) 2002-06-19 2005-11-24 パロマー・メディカル・テクノロジーズ・インコーポレイテッド Method and apparatus for treating skin and subcutaneous conditions
US7856985B2 (en) 2005-04-22 2010-12-28 Cynosure, Inc. Method of treatment body tissue using a non-uniform laser beam
US7586957B2 (en) 2006-08-02 2009-09-08 Cynosure, Inc Picosecond laser apparatus and methods for its operation and use
US8376593B2 (en) 2010-04-30 2013-02-19 Osram Sylvania Inc. Thermal trim for a luminaire
US9439673B2 (en) 2011-01-28 2016-09-13 The General Hospital Corporation Method and apparatus for skin resurfacing
WO2012103483A2 (en) 2011-01-28 2012-08-02 The General Hospital Corporation Apparatus and method for tissue biopsy
SG192167A1 (en) 2011-01-28 2013-08-30 Gen Hospital Corp Method and apparatus for discontinuous dermabrasion
HUE042454T2 (en) 2011-07-21 2019-07-29 Massachusetts Gen Hospital Apparatus for damage and removal of fat
KR102183581B1 (en) 2012-04-18 2020-11-27 싸이노슈어, 엘엘씨 Picosecond laser apparatus and methods for treating target tissues with same
AU2014207245B2 (en) * 2013-01-15 2018-12-06 Heriot Eyecare Pty. Ltd. Method and device for treating retinal detachment
EP4039236A1 (en) 2013-02-20 2022-08-10 Cytrellis Biosystems, Inc. System for tightening a region of skin
EP2973894A2 (en) 2013-03-15 2016-01-20 Cynosure, Inc. Picosecond optical radiation systems and methods of use
PT2991600T (en) 2013-05-03 2018-11-05 Cytrellis Biosystems Inc Microclosures and related methods for skin treatment
KR20230119266A (en) 2013-08-09 2023-08-16 사이트렐리스 바이오시스템즈, 인크. Methods and apparatuses for skin treatment using non-thermal tissue ablation
WO2015095675A1 (en) 2013-12-19 2015-06-25 Cytrellis Biosystems, Inc. Methods and devices for manipulating subdermal fat
US11324534B2 (en) 2014-11-14 2022-05-10 Cytrellis Biosystems, Inc. Devices and methods for ablation of the skin
CA3018976A1 (en) 2016-03-29 2017-10-05 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
US11464954B2 (en) 2016-09-21 2022-10-11 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
WO2019165426A1 (en) 2018-02-26 2019-08-29 Cynosure, Inc. Q-switched cavity dumped sub-nanosecond laser
JP2023544319A (en) * 2020-09-30 2023-10-23 エーエムオー ディベロップメント エルエルシー Re-treatable corneal lenticule incision with re-treatment option using femtosecond ophthalmic laser system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358279B1 (en) * 1999-02-22 2002-03-19 University Of Miami Minicapsulorhexis valve
US6572608B1 (en) * 1999-04-08 2003-06-03 Eric T. Lee Directional laser probe

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7073510B2 (en) * 2000-02-11 2006-07-11 The General Hospital Corporation Photochemical tissue bonding
ES2329669T3 (en) * 2003-04-29 2009-11-30 Medical Technology Transfer Holding B.V. DEVICES AND METHODS TO PREPARE DESCEMET MEMBRANES.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358279B1 (en) * 1999-02-22 2002-03-19 University Of Miami Minicapsulorhexis valve
US6572608B1 (en) * 1999-04-08 2003-06-03 Eric T. Lee Directional laser probe

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
US10285857B2 (en) 2010-09-30 2019-05-14 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
US11033429B2 (en) 2010-09-30 2021-06-15 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
US11135090B2 (en) 2010-09-30 2021-10-05 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
US9555111B2 (en) 2012-03-29 2017-01-31 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
US10092594B2 (en) 2012-03-29 2018-10-09 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
US10575986B2 (en) 2012-03-29 2020-03-03 Cxl Ophthalmics, Llc Ophthalmic treatment solution delivery devices and delivery augmentation methods
US10729716B2 (en) 2012-03-29 2020-08-04 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
US11497766B2 (en) 2012-03-29 2022-11-15 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
US11931291B2 (en) 2012-03-29 2024-03-19 Epion Therapeutics, Inc. Ophthalmic treatment solution delivery devices and delivery augmentation methods

Also Published As

Publication number Publication date
DE602005018557D1 (en) 2010-02-04
EP1933788B1 (en) 2009-12-23
EP1933788A1 (en) 2008-06-25
ATE452610T1 (en) 2010-01-15
US20090312749A1 (en) 2009-12-17
US8795262B2 (en) 2014-08-05

Similar Documents

Publication Publication Date Title
EP1933788B1 (en) Preparing ocular flaps for laser welding
US9814567B2 (en) Method of altering the refractive properties of an eye
EP1272119B1 (en) Photochemical tissue bonding
US9370446B2 (en) Method of altering the refractive properties of an eye
US9155652B2 (en) Method for laser correction of refractive errors of an eye with a thin cornea
US5290272A (en) Method for the joining of ocular tissues using laser light
US9681942B2 (en) Method for prevention of rejection and sever encapsulation of a supportive or functioning implant
US20020006394A1 (en) Photochemical tissue bonding
Rossi et al. Laser tissue welding in ophthalmic surgery
JP6817216B2 (en) Photochemically evoked engagement of intraocular implants
AU2001249984A1 (en) Photochemical tissue bonding
US9681984B2 (en) Method of altering the refractive properties of an eye
Menabuoni et al. Laser-assisted corneal welding in cataract surgery: retrospective study
JP2018508288A5 (en)
Buzzonetti et al. Laser welding in penetrating keratoplasty and cataract surgery in pediatric patients: Early results
Pini et al. Laser tissue welding in minimally invasive surgery and microsurgery
Marcos et al. Toward new engagement paradigms for intraocular lenses: light-initiated bonding of capsular bag to lens materials
Noguera et al. Novel laser-activated solder for sealing corneal wounds
Pini et al. A new technique for the closure of the lens capsule by laser welding
Strassman et al. Laser soldering of the cornea in a rabbit model using a controlled-temperature CO2 laser system
Strassmann et al. Temperature controlled CO2 laser soldering of pig cornea
Norman et al. In vitro conjunctival incision repair by temperature-controlled laser soldering
EP1951174A1 (en) Applicator handpiece for laser-induced suture of the cornea
Menabuoni et al. The use of femtosecond laser and corneal welding in the surgery of keratoconus
Pini et al. Laser welding of biological tissue: experimental studies in ophthalmology

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11991343

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005794513

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005794513

Country of ref document: EP